biological therapy


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

biological therapy

Therapy with immunologically active agents.
References in periodicals archive ?
Biological therapy for dermatological manifestations of inflammatory bowel disease.
Biological therapy was added to the regimen in patients who failed to achieve remission at the maximum tolerable dose of methotrexate.
The contract is for the supply of medicinal products for biological therapy in the Department of Rheumatology at the District Hospital in Radomsko.
Highly stressed hospital workers in Japan reported improved psychological well-being after taking Wellmune WGP, from Biothera, for 2 weeks, according to a new peer-reviewed study published in Biotherapy, the official journal of the Japan Society for Biological Therapy.
The International Society for Biological Therapy of Cancer issued a statement hailing the approval as "a significant advance in the development of biological therapy [also called immunotherapy] for cancer treatment.
An eight-year, 185-patient clinical trial led by the Goshen Center for Cancer Care tested the benefit of combining the gp100 vaccine with the high-dose lnterleuken-2 (IL-2), a biological therapy that boosts the immune system.
The section on biological therapy has been rewritten to reflect the latest developments in the field.
Through 2021, Cimzia will be considered primarily after Remicade and/or Humira, and Tysabri will continue to be relegated to last-line biological therapy.
4 February 2011 - US-based biopharmaceutical company CardioVascular BioTherapeutics Inc (PINK: CVBT) yesterday announced it has submitted an application to the US Food and Drug Administration (FDA) to obtain Fast Track designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1).
Leeroy Blake from Ipswich was fortunate enough to be offered treatment with a biological therapy, after years of trying every other available psoriasis treatment.
Wang (medicine, Stanford University Medical Center) compiles new research in arrhythmia, including pharmacologic therapy, monitoring, risk assessment, and noninvasive mapping, pacing therapy, implantable defibrillators, catheter and surgical ablation, antiarrhythmic biological therapy, and web-based defibrillation monitoring.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that currently, in both China and South Korea, less than one-third of surveyed clinicians' patients who are eligible for a biological therapy are actually receiving one for Crohn's disease (CD) or ulcerative colitis (UC).

Full browser ?